Milestone Pharmaceuticals Inc.

NASDAQ:MIST

Biotechnology

Healthcare
$0.46 -0.01%

-$0.00 today

Market cap
$57.32M
Beta
0.96
P/E (TTM)
-2.5
EPS (TTM)
-$0.52
52W Low $1.00High $3.06

Volume 2.23M

Average 1.99M

Balance Sheet

Inspect the capital base behind the business.

Assets

$113.56M

FY 2025 · Annual

+50.4% YoY

Liabilities

$71.79M

FY 2025 · Annual

+15.1% YoY

Equity

$41.77M

FY 2025 · Annual

+217.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents114.14M7.64M13.76M25.31M73.05M
Short-term Investments056.95M52.24M44.38M32.91M
Net Receivables483K1.21M3.85M2.39M3.51M
Inventory0000648K
Other Current Assets00000
Total Current Assets118.92M71.8M73.03M73.93M111.92M
Property, Plant & Equipment (Net)926K2.68M2.19M1.57M1.64M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets926K2.68M2.19M1.57M1.64M
Total Assets119.85M74.48M75.23M75.5M113.56M
Account Payables4.38M2.26M3.98M1.93M5.65M
Short-term Debt224K495K00647K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities709K808K1.99M(0)5.23M
Total Current Liabilities6.78M6.14M7.23M8.13M13.98M
Long-term Debt0049.77M53.35M57.19M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities000083K
Total Non-current Liabilities474K2M51.23M54.23M57.81M
Total Liabilities7.25M8.14M58.46M62.35M71.79M
Common Stock251.9M273.9M260.5M288.05M352.62M
Retained Earnings(206.32M)(266.34M)(326.03M)(367.55M)(430.6M)
Accumulated OCI51.31M34.35M48.46M53.08M55.65M
Other Stockholders Equity00000
Minority Interest00000
Total Equity112.6M66.35M16.77M13.15M41.77M
Total Debt698K2.49M51.78M54.8M58.38M
Net Debt(113.44M)(5.15M)38.02M29.48M(14.67M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$71.3M
Short-term Investments$112.9M
Receivables$5.0M
Inventory$1.8M
Other Current$1.2M
Total Current Assets$192.3M
PP&E (Net)$1.5M
Total Non-current Assets$1.5M
Total Assets$193.7M

Analysis

Selected assets total $193.7M for Latest. The largest visible component is Short-term Investments at $112.9M, about 58.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 13, 2026
8-KCurrent reportNov 13, 2026
8-KCurrent reportOct 28, 2026
8-KCurrent reportSep 3, 2026
8-KCurrent reportAug 12, 2026

How much cash does MIST have?

Milestone Pharmaceuticals Inc. (MIST) reported $73.05M in cash and equivalents in fiscal 2025.

How much debt does MIST carry?

Milestone Pharmaceuticals Inc. (MIST) reported $58.38M of total debt, with net debt of -$14.67M.